CoChat

Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand

Open access
Li, Jiang, Kuruba, Ramalinga, Wilson, Annette, Gao, Xiang, Zhang, Yifei, Li, Song · 2010 · PLoS ONE

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen and the enhanced contractile response to vasoactive mediators such as endothelin-1 (ET-1). The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that is highly expressed in liver, kidneys, adrenals, and intestine. FXR is also expressed in HSCs and activation of FXR in HSCs is associated with significant decreases in collagen production. However, little is known about the roles of FXR in the regulation of contraction of HSCs. We report in this study that treatment of quiescent HSCs with GW4064, a synthetic FXR agonist, significantly inhibited the HSC transdifferentiation, which was associated with an inhibition of the upregulation of ET-1 expression. These GW4064-treated cells also showed reduced contractile response to ET-1 in comparison to HSCs without GW4064 treatment. We have further shown that GW4064 treatment inhibited the ET-1-mediated contraction in fully activated HSCs. To elucidate the potential mechanism we showed that GW4064 inhibited ET-1-mediated activation of Rho/ROCK pathway in activated HSCs. Our studies unveiled a new mechanism that might contribute to the anti-cirrhotic effects of FXR ligands.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0013955

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 GW4064 treatment inhibited transdifferentiation of HSCs. Freshly isolated rat HSCs were cultured for 7 days in 10% FCS alone (control) or 10% FCS medium containing 1 µmol/L GW4064. The expression of α-SMA mRNA (A) and protein (B) was examined by real-time RT-PCR and immunofluorescence staining, respectively. Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.
Figure 1 GW4064 treatment inhibited transdifferentiation of HSCs. Freshly isolated rat HSCs were cultured for 7 days in 10% FCS alone (control) or 10% FCS medium containing 1 µmol/L GW4064. The expression of α-SMA mRNA (A) and protein (B) was examined by real-time RT-PCR and immunofluorescence staining, respectively. Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.CC BY · PubMed Central
Figure 2 GW4064 treatment inhibited the upregulation of ET-1 expression during HSC activation. Freshly isolated rat HSCs were cultured for 7 days in 10% FCS alone (control) or 10% FCS medium containing 1 µmol/L GW4064. The mRNA expression levels of ET-1 (A), ETB (B) and ETA (C) were examined by real-time RT-PCR, respectively. Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.
Figure 2 GW4064 treatment inhibited the upregulation of ET-1 expression during HSC activation. Freshly isolated rat HSCs were cultured for 7 days in 10% FCS alone (control) or 10% FCS medium containing 1 µmol/L GW4064. The mRNA expression levels of ET-1 (A), ETB (B) and ETA (C) were examined by real-time RT-PCR, respectively. Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.CC BY · PubMed Central
Figure 3 GW4064 treatment of HSCs led to reduced contractile response to ET-1. Freshly isolated rat HSCs were cultured for 7 days in 10% FCS medium alone (control) or 10% FCS medium containing 1 µmol/L GW4064. Collagen gel lattices that contained the control or GW4064-treated HSCs were prepared as described in Materials & Methods . Hydrated collagen lattices were photographed 6 hours after addition of ET-1 (10 nM). Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.
Figure 3 GW4064 treatment of HSCs led to reduced contractile response to ET-1. Freshly isolated rat HSCs were cultured for 7 days in 10% FCS medium alone (control) or 10% FCS medium containing 1 µmol/L GW4064. Collagen gel lattices that contained the control or GW4064-treated HSCs were prepared as described in Materials & Methods . Hydrated collagen lattices were photographed 6 hours after addition of ET-1 (10 nM). Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.CC BY · PubMed Central
Figure 4 GW4064 treatment inhibited ET-1-induced contraction in fully activated HSCs. Rat HSCs were isolated and then cultured for 7 days to allow full activation. Collagen gel lattices that contained fully activated HSCs were then prepared. They were treated with DMSO or 1 µmol/L GW4064 for 18 hours. Hydrated collagen lattices were photographed 6 hours after addition of ET-1 (10 nM). Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.
Figure 4 GW4064 treatment inhibited ET-1-induced contraction in fully activated HSCs. Rat HSCs were isolated and then cultured for 7 days to allow full activation. Collagen gel lattices that contained fully activated HSCs were then prepared. They were treated with DMSO or 1 µmol/L GW4064 for 18 hours. Hydrated collagen lattices were photographed 6 hours after addition of ET-1 (10 nM). Data are mean ±SE of 6 experiments. *P<.001 vs. control cells.CC BY · PubMed Central
Figure 5 GW4064 treatment inhibited ET-1-induced RhoA activation in activated HSCs. Activated HSCs were treated with DMSO or 1 µmol/L GW4064 for 18 hours. ET-1 (10 nM) was then added to the medium, and the cells were harvested 10 min later. RhoA-GTP pull-down assay was performed using RhoA-GTP assay kit. RhoA-GTP pull-down and total RhoA fractions were probed by Western blot with anti-RhoA antibody. Blots are representative of experiments performed three times with similar results.
Figure 5 GW4064 treatment inhibited ET-1-induced RhoA activation in activated HSCs. Activated HSCs were treated with DMSO or 1 µmol/L GW4064 for 18 hours. ET-1 (10 nM) was then added to the medium, and the cells were harvested 10 min later. RhoA-GTP pull-down assay was performed using RhoA-GTP assay kit. RhoA-GTP pull-down and total RhoA fractions were probed by Western blot with anti-RhoA antibody. Blots are representative of experiments performed three times with similar results.CC BY · PubMed Central
Figure 6 GW4064 treatment inhibited ET-1-induced Rho-kinase activity in activated HSCs. Activated HSCs were treated with DMSO or 1 µmol/L GW4064 for 18 hours. ET-1 (10 nM) was then added to the medium, and the cells were harvested 10 min later. Phosphorylation of meosin was detected by Western using appropriate phospho-specific antibody. An immunoblot of total meosin present in the cell extracts is shown as a loading control (lower panel). A representative immunoblot from three independent experiments is presented.
Figure 6 GW4064 treatment inhibited ET-1-induced Rho-kinase activity in activated HSCs. Activated HSCs were treated with DMSO or 1 µmol/L GW4064 for 18 hours. ET-1 (10 nM) was then added to the medium, and the cells were harvested 10 min later. Phosphorylation of meosin was detected by Western using appropriate phospho-specific antibody. An immunoblot of total meosin present in the cell extracts is shown as a loading control (lower panel). A representative immunoblot from three independent experiments is presented.CC BY · PubMed Central
Figure 7 GW4064 treatment inhibited ET-1-induced phosphorylation of MLC in activated HSCs. Activated HSCs were treated with DMSO or 1 µmol/L GW4064 for 18 hours. ET-1 (10 nM) was then added to the medium, and the cells were harvested 10 min later. Phosphorylation of MLC was detected by Western using appropriate phospho-specific antibody. An immunoblot of total MLC present in the cell extracts is shown as a loading control (lower panel). A representative immunoblot from three independent experiments is presented.
Figure 7 GW4064 treatment inhibited ET-1-induced phosphorylation of MLC in activated HSCs. Activated HSCs were treated with DMSO or 1 µmol/L GW4064 for 18 hours. ET-1 (10 nM) was then added to the medium, and the cells were harvested 10 min later. Phosphorylation of MLC was detected by Western using appropriate phospho-specific antibody. An immunoblot of total MLC present in the cell extracts is shown as a loading control (lower panel). A representative immunoblot from three independent experiments is presented.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 66

Metadata

Authors
Li, J., Kuruba, R., Wilson, A., Gao, X., Zhang, Y., & Li, S.
Affiliations
University of Pittsburgh (US)
Corresponding author
Li, Song
Venue
PLoS ONE
Published
2010-11-11
Volume
5
Issue
11
Pages
e13955
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2008996867
Cited by
66
References
31
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2022: 10 · 2021: 9 · 2020: 3 · 2019: 6 · 2018: 10 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 3 · 2012: 4
FWCI
1.47
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL091828, R01HL091828)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
hepatic stellate cells, endothelin-1, farnesoid X receptor, FXR agonists, GW4064, cell contraction, liver cirrhosis, Rho/ROCK signaling, collagen synthesis
MeSH terms
Receptor, Farnesoid X-Activated, Animals, Cells, Cultured, Gene Expression Regulation, Isoxazoles, Male, Microfilament Proteins, Phosphorylation, Blotting, Western, Signal Transduction, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Endothelin-1, Reverse Transcriptase Polymerase Chain Reaction, Cell Shape, Rats, Cell Transdifferentiation, rho-Associated Kinases, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand. https://app.cochat.ai/papers/10.1371/journal.pone.0013955
The paper
Li, J., Kuruba, R., Wilson, A., Gao, X., Zhang, Y., & Li, S. (2010). Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand. PLoS ONE. https://doi.org/10.1371/journal.pone.0013955

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.